If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
800.50    5.50 (0.69%)
Bid:
801.00
Ask:
801.50
Spread: 0.50 (0.062%)
Market Cap: £1.61b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Update on Secondary Placing

13 Apr 2016 07:00

RNS Number : 0005V
Dunelm Group plc
13 April 2016
 

Dunelm Group plc

13 April 2016

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

SECONDARY PLACING OF ORDINARY SHARES IN DUNELM GROUP PLC

("DUNELM" OR "THE COMPANY")

 

Further to the previous announcement, Dunelm announces it has been advised that Will Adderley, Deputy Chairman, has sold 8.0 million shares in the Company, representing approximately 4.0 per cent of the issued share capital of Dunelm. The shares were placed at a price of 915 pence per share.

 

The shares sold and residual holdings are as follows:

 

Shares sold

Residual holding

Will Adderley

71,476

0

WA Capital Limited

7,728,524

54,161,779

The Stoneygate Trust

200,000

967,250

Total

8,000,000

55,129,029

 

WA Capital Limited is a company controlled by Will and Nadine Adderley; The Stoneygate Trust is a charity of which Will and Nadine Adderley are trustees.

 

Following these disposals, Will Adderley continues to have an interest in 55.3 million shares in the Company, which includes 172,750 shares held in the Paddocks Trust, of which he and his wife Nadine Adderley are trustees but not beneficiaries. In total, this represents 27.4 per cent of the issued share capital. The Adderley family as a whole retains a combined interest in 103.4 million shares in the Company, representing 51.2 per cent of the issued share capital.

 

The shares were sold to institutional investors in a placing managed by UBS Limited, acting as Bookrunner, and Stifel Nicolaus Europe Limited, acting as Co-Lead Manager.

 

The Company purchased 750,000 shares for transfer into treasury with the intention of re-issuing them to satisfy employee share based award obligations that arise in the future.

 

Will Adderley remains fully committed to Dunelm in his role as Deputy Chairman as well as remaining a very substantial shareholder in the Company.

 

Under the terms of the placing agreement, Will Adderley has agreed not to dispose of further shares in the Company for a period of at least six months.

 

Enquiries:

UBS Limited +44 (0)20 7567 8000

Craig Calvert

Christopher Smith

Stifel Nicolaus Europe Limited +44 (0)20 7710 7600

Eithne O'Leary

David Arch

 

MHP Communications +44 (0) 20 3128 8100

John Olsen

Simon Hockridge

 

Each of UBS Limited and and Stifel Nicolaus Europe Limited is acting on the Placing and will not be responsible to anyone other than its client for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement, or any transaction or arrangement referred to herein.

This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of Dunelm, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction, including the United States, Canada, Australia or Japan. Dunelm's shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under the securities legislation of any state of the United States and may not be offered or sold in the United States absent registration or an exemption from registration.

Dunelm's shares may not, directly or indirectly, be offered or sold within the United States, Canada, Australia or Japan or offered or sold to a resident of Canada, Australia or Japan. No public offering of securities is being made in the United States.

This announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted into Australia, Canada or Japan or to Canadian persons or to any securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian or Japanese securities law. The distribution of this announcement in certain other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement and any offer of securities to which it relates are only addressed to and directed at persons who are (1) qualified investors within the meaning of directive 2003/71/ec and any relevant implementing measures (the prospectus directive) and (2) who have professional experience in matters relating to investments who fall within article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or are persons falling within article 49(2)(a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc") of the Order (all such persons together being referred to as "relevant persons"). The information regarding the Placing set out in this announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWEEEFMSEEL
Date   Source Headline
2nd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights
9th Sep 20257:00 amRNSPreliminary Results
31st Jul 20257:00 amRNSTotal Voting Rights
17th Jul 20257:00 amRNSFourth quarter and full year trading update
14th Jul 202512:30 pmRNSDirector Declaration
7th Jul 202512:30 pmRNSAppointment of CEO
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTotal Voting Rights
8th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSAppointment of Katharine Poulter as NED
30th Apr 20257:00 amRNSTotal Voting Rights
17th Apr 20257:00 amRNSThird quarter trading update
14th Apr 20257:00 amRNSBlock Listing Six Monthly Return
1st Apr 20259:50 amRNSTotal Voting Rights
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20251:00 pmRNSPurchases of Shares During Open Periods
11th Feb 20257:00 amRNSCEO succession
11th Feb 20257:00 amRNSInterim Results
31st Jan 20257:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSSecond quarter and first half trading update
31st Dec 20247:00 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSDirector Declaration
29th Nov 202411:00 amRNSTotal Voting Rights
21st Nov 20243:18 pmRNSResults of AGM
20th Nov 20247:00 amRNS-RAcquisition of Home Focus
1st Nov 20241:00 pmRNSDirector/PDMR Shareholding
31st Oct 202411:00 amRNSTotal Voting Rights
30th Oct 20243:00 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSFirst quarter trading update
18th Oct 20244:00 pmRNSSale of Shares by Concert Party and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.